Casi DeYoung

Casi DeYoung

Corporate Officer/Principal bij SHATTUCK LABS, INC.

Vermogen: 509 951 $ op 30-06-2026

55 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Casi DeYoung is currently Chief Business Officer at Shattuck Labs, Inc. since 2019.
Former roles include Operations Director-Oncology at Merck KGaA, Operations Director-Oncology at EMD Pharmaceuticals, Inc. from 2000 to 2005, Consulting Manager at Accenture Ltd., Vice President-Business Development at Reata Pharmaceuticals, Inc. from 2008 to 2013, Vice President-Business Development at ODC Therapy, Inc. from 2005 to 2008, Chief Business Officer at Mirna Therapeutics, Inc. from 2014 to 2017, and Chief Operating Officer & Vice President at ImmuneSensor Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Southwestern University and an MBA from McCombs School of Business.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
25-01-2026 73.480 ( 0,08% ) 509 951 $ 30-06-2026

Actieve functies van Casi DeYoung

BedrijvenFunctieBegin
SHATTUCK LABS, INC. Corporate Officer/Principal 01-12-2019

Eerdere bekende functies van Casi DeYoung

BedrijvenFunctieEinde
Operationeel Directeur 01-12-2019
Public Communications Contact 01-06-2017
REATA PHARMACEUTICALS, INC. Corporate Officer/Principal 01-12-2013
Corporate Officer/Principal 01-03-2008
Corporate Officer/Principal 01-01-2005
Ervaring van Casi DeYoung in detail bekijken

Opleiding van Casi DeYoung

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

35

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Commercial Services

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Casi DeYoung